Roche says cancer drug MabThera extends survival
630959
Roche Holding AG on Monday said new data showed cancer drug MabThera significantly extended survival and cured more patients with aggressive lymphoma than chemotherapy alone.
766797
Genentech Inc.  on Monday said its colon cancer drug Avastin extended the life of patients when used in combination with a chemotherapy regimen called FOLFOX4 more than the chemotherapy alone in a late stage clinical trial.
521918
The new Genentech, Inc., cancer drug Avastin appears to extend survival for patients with colorectal cancer by nearly two months, US National Cancer Institute researchers have concluded.
470821
The drugs docetaxel and estramustine can increase survival by a few months in men whose prostate cancer has spread to other parts of the body, two new studies find.
462626
CHICAGO -- For the first time, doctors say they have found a pill that improves survival for people with liver cancer, a notoriously hard to treat disease diagnosed in more than half a million people globally each year.
24114
An experimental treatment tripled the survival rate of men with advanced prostate cancer in a clinical trial, doctors said yesterday, a result they said represents perhaps the first significant success for therapies known as cancer vaccines.
638758
A pill that starves tumors of their blood supply can help patients live longer, without adding to some of the worst effects of chemotherapy, researchers reported on Thursday.
702358
A pill that starves tumors of their  blood supply can help patients live longer, without adding to  some of the worst effects of chemotherapy, researchers reported  on Thursday.
225228
BOSTON (CBS.MW) - Shares of Genentech were halted on Monday as the company announced that its oncology drug Avastin had been shown to extend the lives of some patients stricken with advanced colorectal cancer.
229940
Swiss drugmaker Novartis AG's  cancer-fighting drug Gleevec can still help treat chronic  myeloid leukemia even after five years of use, a new study  showed on Wednesday.
57060
WASHINGTON -- Women with an aggressive form of advanced breast cancer that other treatments have failed to stop gained a new option yesterday with the approval of a novel drug -- but how much benefit it offers is unclear.
632778
More than a quarter of patients with advanced kidney cancer saw their tumors shrink after treatment with GlaxoSmithKline Plc's pazopanib, a new pill designed to rival Genentech's blockbuster drug Avastin, researchers said on Saturday.
240246
Swiss drugmaker Novartis AG's cancer-fighting drug Gleevec can still help treat chronic myeloid leukemia even after five years of use, a new study showed on Wednesday.
719738
Genentech Inc. on Monday said its colon cancer drug Avastin extended the life of patients when used in combination with a chemotherapy regimen called FOLFOX4 more than the chemotherapy alone in a late stage clinical trial.
138016
Adding ImClone Systems Inc.&#39;s Erbitux  to a regimen of chemotherapy prolonged survival more than  chemotherapy alone in patients with head and neck cancer that  has recurred or spread, according to a study.
550204
CHICAGO/NEW YORK  - When it comes to the price tag  for the newest biotechology drugs for cancer and other  hard-to-treat diseases, the sky is likely to remain the limit,  insurers, drugmakers and industry watchers say.
131634
More than a quarter of patients with  advanced kidney cancer saw their tumors shrink after treatment  with GlaxoSmithKline Plc&#39;s pazopanib, a new pill designed to  rival Genentech&#39;s blockbuster drug Avastin, researchers said on  Saturday.